BusinessAXIM® Biotech Receives Positive PK Data Results for CanChew Plus® CBD GumBy Nasdaq OMXJan 4, 2017, 2:04 PM UTC
BusinessAXIM® Biotech Receives Positive PK Data Results for CanChew Plus® CBD GumBy Nasdaq OMXJan 4, 2017, 2:03 PM UTC
BusinessBreakthrough Surgical Sealant Designed to Help Reduce Anastomotic Leaks for Patients Undergoing Colorectal SurgeryBy Nasdaq OMXJan 3, 2017, 2:15 PM UTC
BusinessCascadian Therapeutics Amends HER2CLIMB Phase 2 Trial of Tucatinib in Metastatic HER2-Positive Breast Cancer to Support RegistrationBy Nasdaq OMXDec 7, 2016, 12:00 PM UTC
BusinessAdaptimmune Announces Initiation of Myxoid/Round Cell Liposarcoma StudyBy Nasdaq OMXDec 5, 2016, 12:30 PM UTC
BusinessAchillion Announces Initiation of Patient Dosing by Janssen in a Global, Short Treatment-Duration Phase 2b Study of JNJ-4178 in Chronic HCVBy Nasdaq OMXNov 30, 2016, 11:05 AM UTC
BusinessSummit Enrols Patients in the United States Into PhaseOut DMD, a Phase 2 Clinical Trial of Ezutromid in Patients With DMDBy Nasdaq OMXNov 16, 2016, 12:00 PM UTC
BusinessBreakthrough Clinical Trial to be featured on CNN: Reductions in Suicidality, Depression, and Post-Traumatic StressBy Nasdaq OMXNov 11, 2016, 12:00 AM UTC
